Please login to the form below

Not currently logged in
Email:
Password:

US

This page shows the latest US news and features for those working in and with pharma, biotech and healthcare.

Novartis’ heart failure drug Entresto proves superior to enalapril

Novartis’ heart failure drug Entresto proves superior to enalapril

In the US it is indicated for the treatment of heart failure in patients with systolic dysfunction.

Latest news

More from news
Approximately 151 fully matching, plus 2,063 partially matching documents found.

Latest Intelligence

  • Nudge-nudge, think-think Nudge-nudge, think-think

    However, through the behavioural sciences, we now have a systematic framework for understanding the techniques, nudges and interventions that can help us trigger and sustain behaviour change.

  • The handover: Pfizer reshapes itself for a new era The handover: Pfizer reshapes itself for a new era

    The Trump administration has also just floated the idea of pegging US (Medicare part B) drug prices to other countries, aka international reference pricing. ... These battles over pricing and access in the US market remain among the biggest priorities

  • Brexit: can pharma ‘take back control’ of the narrative? Brexit: can pharma ‘take back control’ of the narrative?

    Our clients and contacts tell us that Brexit continues to present significant uncertainty for the life sciences industry, with time running out for companies to be able to implement the necessary

  • Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe

    Vyndaqel has been available in Europe since 2011 for Transthyretin (TTR) amyloid polyneuropathy, but isn’t yet approved in the US. ... In the US and Canada, the company has launched Alynlam Act, a free of charge genetic testing and counselling service.

  • Lonely planet: why there is dwindling value in pharma travelling alone Lonely planet: why there is dwindling value in pharma travelling alone

    With the 2020 milestone almost upon us, evidence suggests that the central prediction of the PwC report has proved to be correct. ... Collaborating for value. “Europe is in the grip of a sustainability and transformation phase that’s forcing us all

More from intelligence
Approximately 11 fully matching, plus 520 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 741 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 16 fully matching, plus 928 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Just::Health Communications

Just:: is a different kind of healthcare communications agency. Since 2006, we’ve been collaborating with clients around the world to...

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Infographics